According to the latest data from the Hong Kong Stock Exchange, on July 10th, a prominent mutual fund management company increased its holdings in CSPC PHARMA (01093) by 7.368 million shares. The transaction was executed at an average price of approximately HK$8.14 per share, resulting in a total investment of around HK$59.96 million.

Following this strategic acquisition, the fund's total shareholding in the pharmaceutical company has risen to approximately 583 million shares. This represents a significant ownership stake of 5.05% in the company.